Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @LaurenLaidlaw1
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @LaurenLaidlaw1
-
Want to learn more are the top 5 violations the DEP sees most? Check out the
@Safety_Partners weekly blog.#SaferTogetherhttps://twitter.com/Safety_Partners/status/1164175428455731202 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Be Prepared! The upcoming 6th version of the BMBL will include an appendix on Large Scale Biosafety. Other new appendices submitted for review for the BMBL update include Inactivation, Sustainability, and Clinical Laboratory Biosafety. https://bit.ly/2XXEJZG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
April 2019 NIH Guidelines update streamlines the oversight of human gene transfer (HGT) research - learn about it in this week's blog post!https://twitter.com/Safety_Partners/status/1130957785783525376 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Excited to have Beth Graham posting our weekly blog! Let us know what you want to learn about!https://twitter.com/Safety_Partners/status/1126134444920905728 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lauren Laidlaw proslijedio/la je Tweet
Safety Tip: Bloodborne Pathogen Training Reminder Sarah Mueller explains how important it is to come up with a plan to keep people safe from bloodborne pathogen exposure in this week's blog post.
#safety#EHS#biosafety Read More: http://www.safetypartnersinc.com/2019/03/bloodborne-pathogen-training-reminder/ …pic.twitter.com/GQrep5dq7F
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Synspira Therapeutics Announces Appointment of Robert Gallotto as President and Chief Executive Officerhttps://prn.to/2TP8zh0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lauren Laidlaw proslijedio/la je Tweet
Safety Tip: Be sure to reconcile the Safety Data Sheets at your facility to verify that you have an SDS for all hazardous chemicals present on site. Learn more: http://www.safetypartnersinc.com/2019/03/reconcile-safety-data-sheets/ …pic.twitter.com/apLbCWJXhl
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
UPDATED: Bristol-Myers inks a $74B deal to buy out Celgene, expects $15B a year from late-stage pipeline -https://endpts.com/bristol-myers-inks-a-74b-deal-to-buy-out-celgene-expects-15b-a-year-from-late-stage-pipeline/ …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lauren Laidlaw proslijedio/la je Tweet
Does your facility have an established policy that clearly specifies whether cell phones are permitted into the lab while conducting work? Sarah Mueller explains why personal property restrictions are so important in infectious lab spaces!
#BioSafety http://ow.ly/2YZQ50jRwei pic.twitter.com/LtWSg4LlDB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Introducing SVB Leerink: SVB bags Leerink Partners for $280M as a major player spreads its wings during a life ... -https://endpts.com/svb-bags-leerink-partners-for-280m-as-a-major-player-spreads-its-wings-during-a-life-sciences-boom/ …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Deerfield bankrolls an $80M research center at Dana-Farber devoted to protein degradation -https://endpts.com/deerfield-bankrolls-an-80m-research-center-at-dana-farber-devoted-to-protein-degradation/ …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Check out our weekly Safety Tip on top OSHA violations... #2 on the list is Hazard Communication, with 4,552 violations!https://twitter.com/Safety_Partners/status/1057603246120988672 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Keeping employees safe...Read this week's Safety Tip on risk groups for biological agents.https://twitter.com/Safety_Partners/status/1044702574736273408 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A GREAT CAUSE! Hope to see many friends and colleagues there!https://twitter.com/Safety_Partners/status/1040339195556966401 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
There are many moving parts involved with the launch of the e-Manifest system, which occurred over the summer. Make sure you know what you need to do!https://twitter.com/Safety_Partners/status/1042417561940492288 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug https://www.xconomy.com/boston/2018/08/10/alnylam-gets-landmark-fda-ok-for-first-ever-rnai-drug/ … via
@xconomyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congratulations to Tom Hughes
@TEHughes2009 now CEO@NavitorPharma! Exciting new chapter begins!https://twitter.com/NavitorPharma/status/1025123822465441793 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Looking forward to hearing my friend Aaron Schwartz speak at Monday's NE Healthcare Executive Network's Social! https://bit.ly/2JWxBpE
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
An often overlooked EHS best practice – don’t forget!https://twitter.com/Safety_Partners/status/1022207987459522560 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Agios scores its second new drug approval, ivosidenib heads to the AML market -https://endpts.com/agios-scores-its-second-new-drug-approval-ivosidenib-heads-to-the-aml-market/ …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.